The global assistive reproductive technology market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of infertility cases and rising awareness about assisted reproductive technologies among couples. The IVF segment accounted for the largest share in the global market in 2018, followed by AIUI and FER segments. In terms of application, fertility clinics accounted for the largest share in 2018, followed by IVF centers and hospitals. North America was estimated to account for the largest share in 2018 due to high adoption rates of assisted reproductive technologies among couples as well as favorable government policies towards these treatments.
Some Of The Growth Factors Of This Market:
- The global population is aging and the number of people over 65 years old is expected to double by 2050.
- The global population is growing and the number of people over 65 years old is expected to double by 2050.
- There are more women in their reproductive age than ever before, which means there will be a greater demand for assisted reproductive technology in the future as well as a higher chance of success with these treatments.
- More couples are choosing to have children later in life, which means they may need assistance with fertility treatments.
- Advances in technology have made it possible for more people to afford these treatments.
Industry Growth Insights published a new data on “Assistive Reproductive Technology Market”. The research report is titled “Assistive Reproductive Technology Market research by Types (In-vitro fertilization (IVF), Artificial Insemination-Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), Other, Assistive Reproductive Technolog), By Applications (Fertility Clinics, IVF Center, Hospital), By Players/Companies Cooper Surgical, Hamilton Thorne, FUJIFILM Irvine Scientific, Nidacon International, Vitrolife AB, Merck, INVO Bioscience, IVFtech, Gonagen Medikal, Cook Medical, CellCura, Assistive Reproductive Technolog”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Assistive Reproductive Technology Market Research Report
By Type
In-vitro fertilization (IVF), Artificial Insemination-Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), Other, Assistive Reproductive Technolog
By Application
Fertility Clinics, IVF Center, Hospital
By Companies
Cooper Surgical, Hamilton Thorne, FUJIFILM Irvine Scientific, Nidacon International, Vitrolife AB, Merck, INVO Bioscience, IVFtech, Gonagen Medikal, Cook Medical, CellCura, Assistive Reproductive Technolog
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Assistive Reproductive Technology Market Report Segments:
The global Assistive Reproductive Technology market is segmented on the basis of:
Types
In-vitro fertilization (IVF), Artificial Insemination-Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), Other, Assistive Reproductive Technolog
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Fertility Clinics, IVF Center, Hospital
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cooper Surgical
- Hamilton Thorne
- FUJIFILM Irvine Scientific
- Nidacon International
- Vitrolife AB
- Merck
- INVO Bioscience
- IVFtech
- Gonagen Medikal
- Cook Medical
- CellCura
- Assistive Reproductive Technolog
Highlights of The Assistive Reproductive Technology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- In-vitro fertilization (IVF)
- Artificial Insemination-Intrauterine Insemination (AI-IUI)
- Frozen Embryo Replacement (FER)
- Other
- Assistive Reproductive Technolog
- By Application:
- Fertility Clinics
- IVF Center
- Hospital
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Assistive Reproductive Technology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Assistive reproductive technology (ART) is a term used to describe various techniques and technologies that can be used to help couples conceive or improve their chances of conceiving. ART includes everything from fertility treatments like in vitro fertilization (IVF) and artificial insemination (AI), to assisted reproductive technologies like intrauterine devices (IUDs) and sperm donation.
Some of the major companies in the assistive reproductive technology market are Cooper Surgical, Hamilton Thorne, FUJIFILM Irvine Scientific, Nidacon International, Vitrolife AB, Merck, INVO Bioscience, IVFtech, Gonagen Medikal, Cook Medical, CellCura, Assistive Reproductive Technolog.
The assistive reproductive technology market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Assistive Reproductive Technology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Assistive Reproductive Technology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Assistive Reproductive Technology Market - Supply Chain
4.5. Global Assistive Reproductive Technology Market Forecast
4.5.1. Assistive Reproductive Technology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Assistive Reproductive Technology Market Size (000 Units) and Y-o-Y Growth
4.5.3. Assistive Reproductive Technology Market Absolute $ Opportunity
5. Global Assistive Reproductive Technology Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Assistive Reproductive Technology Market Size and Volume Forecast by Type
5.3.1. In-vitro fertilization (IVF)
5.3.2. Artificial Insemination-Intrauterine Insemination (AI-IUI)
5.3.3. Frozen Embryo Replacement (FER)
5.3.4. Other
5.3.5. Assistive Reproductive Technolog
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Assistive Reproductive Technology Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Assistive Reproductive Technology Market Size and Volume Forecast by Application
6.3.1. Fertility Clinics
6.3.2. IVF Center
6.3.3. Hospital
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Assistive Reproductive Technology Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Assistive Reproductive Technology Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Assistive Reproductive Technology Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Assistive Reproductive Technology Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Assistive Reproductive Technology Demand Share Forecast, 2019-2026
9. North America Assistive Reproductive Technology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Assistive Reproductive Technology Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Assistive Reproductive Technology Market Size and Volume Forecast by Application
9.4.1. Fertility Clinics
9.4.2. IVF Center
9.4.3. Hospital
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Assistive Reproductive Technology Market Size and Volume Forecast by Type
9.7.1. In-vitro fertilization (IVF)
9.7.2. Artificial Insemination-Intrauterine Insemination (AI-IUI)
9.7.3. Frozen Embryo Replacement (FER)
9.7.4. Other
9.7.5. Assistive Reproductive Technolog
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Assistive Reproductive Technology Demand Share Forecast, 2019-2026
10. Latin America Assistive Reproductive Technology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Assistive Reproductive Technology Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Assistive Reproductive Technology Market Size and Volume Forecast by Application
10.4.1. Fertility Clinics
10.4.2. IVF Center
10.4.3. Hospital
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Assistive Reproductive Technology Market Size and Volume Forecast by Type
10.7.1. In-vitro fertilization (IVF)
10.7.2. Artificial Insemination-Intrauterine Insemination (AI-IUI)
10.7.3. Frozen Embryo Replacement (FER)
10.7.4. Other
10.7.5. Assistive Reproductive Technolog
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Assistive Reproductive Technology Demand Share Forecast, 2019-2026
11. Europe Assistive Reproductive Technology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Assistive Reproductive Technology Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Assistive Reproductive Technology Market Size and Volume Forecast by Application
11.4.1. Fertility Clinics
11.4.2. IVF Center
11.4.3. Hospital
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Assistive Reproductive Technology Market Size and Volume Forecast by Type
11.7.1. In-vitro fertilization (IVF)
11.7.2. Artificial Insemination-ntrauterine Insemination (AI-IUI)
11.7.3. Frozen Embryo Replacement (FER)
11.7.4. Other
11.7.5. Assistive Reproductive Technolog
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Assistive Reproductive Technology Demand Share, 2019-2026
12. Asia Pacific Assistive Reproductive Technology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Assistive Reproductive Technology Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Assistive Reproductive Technology Market Size and Volume Forecast by Application
12.4.1. Fertility Clinics
12.4.2. IVF Center
12.4.3. Hospital
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Assistive Reproductive Technology Market Size and Volume Forecast by Type
12.7.1. In-vitro fertilization (IVF)
12.7.2. Artificial Insemination-Intrauterine Insemination (AI-IUI)
12.7.3. Frozen Embryo Replacement (FER)
12.7.4. Other
12.7.5. Assistive Reproductive Technolog
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Assistive Reproductive Technology Demand Share, 2019-2026
13. Middle East & Africa Assistive Reproductive Technology Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Assistive Reproductive Technology Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Assistive Reproductive Technology Market Size and Volume Forecast by Application
13.4.1. Fertility Clinics
13.4.2. IVF Center
13.4.3. Hospital
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Assistive Reproductive Technology Market Size and Volume Forecast by Type
13.7.1. In-vitro fertilization (IVF)
13.7.2. Artificial Insemination-Intrauterine Insemination (AI-IUI)
13.7.3. Frozen Embryo Replacement (FER)
13.7.4. Other
13.7.5. Assistive Reproductive Technolog
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Assistive Reproductive Technology Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Assistive Reproductive Technology Market: Market Share Analysis
14.2. Assistive Reproductive Technology Distributors and Customers
14.3. Assistive Reproductive Technology Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Cooper Surgical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Hamilton Thorne
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. FUJIFILM Irvine Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Nidacon International
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Vitrolife AB
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Merck
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. INVO Bioscience
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. IVFtech
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Gonagen Medikal
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cook Medical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. CellCura
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Assistive Reproductive Technolog
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
